ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,005,027 | -70.4% | 664,829 | -26.3% | 0.06% | -72.5% |
Q4 2022 | $10,165,540 | +17.8% | 902,000 | 0.0% | 0.20% | +17.6% |
Q3 2022 | $8,632,000 | -64.1% | 902,000 | +105.0% | 0.17% | -47.4% |
Q2 2021 | $24,056,000 | +262.5% | 439,950 | +388.8% | 0.32% | +229.6% |
Q1 2021 | $6,637,000 | – | 90,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $46,559,640 | 13.20% |
Vivo Capital, LLC | 4,220,048 | $20,256,230 | 2.22% |
Logos Global Management LP | 1,000,000 | $4,800,000 | 0.64% |
Orbimed Advisors | 2,871,000 | $13,780,800 | 0.29% |
Redmile Group, LLC | 1,283,289 | $6,159,787 | 0.29% |
BRAIDWELL LP | 1,249,900 | $5,999,520 | 0.19% |
Cormorant Asset Management, LP | 612,079 | $2,937,979 | 0.17% |
Nan Fung Group Holdings Ltd | 41,950 | $201,360 | 0.16% |
Forefront Analytics, LLC | 13,769 | $66,092 | 0.04% |
CORNERCAP INVESTMENT COUNSEL INC | 35,071 | $168,341 | 0.03% |